INternational Spondyloarthritis Inter- observer Reliability Exercise – the INSPIRE study. Gladman DD, Inman RD, Cook R, Maksymowych W, van der Heijde D,

Slides:



Advertisements
Similar presentations
Psoriatic Arthritis: Creating a Model for Cost- Effectiveness Analysis GRAPPA meeting San Antonio, TX October 15, 2004 Supported by Schering Participants:
Advertisements

Copyright © 2013 Lippincott Williams & Wilkins. Unauthorized commercial reproduction of this slide is prohibited Supplemental PowerPoint Slides Assessments.
Identifying Domains of Inquiry in Psoriatic Arthritis Dafna D. Gladman, Professor of Medicine, University of Toronto, Director, Psoriatic Arthritis Program.
First International Psoriatic Arthritis Working Group Meeting: 8/15-17/03 NYC Philip Mease MD.
Immune Risk Phenotype Dr. Gabriele Rumi. Effect of the genetic background and aging on the immune system.
SPONDYLOARTROPATHIES
Etanercept (Enbrel®) for the Treatment of Ankylosing Spondylitis
A complex and severe disabling disease
Spondyloarthritis Khusrow Khidri Spondyloarthritis (or spondyloarthropathy) is the name for a family of inflammatory rheumatic diseases that cause.
GRAPPA Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Philip Mease MD.
Applying Deliberate Practice to Plastic Surgery Residency Training Jack Burns, MS 1 ; Jeffrey Cone, MD 2 ; Jessica Ching, MD 2 ; Paul Smith, MD 2 1 Morsani.
Psoriatic arthritis – definition and classification criteria Philip Helliwell Senior Lecturer in Rheumatology University of Leeds.
ANKYLOSING SOPNDYLITIS 僵直性脊椎炎. Definition AS is an inflammatory disorder of unknown etiology that primarily affects the spine, axial skeleton, and large.
ASAS – recent achievements
An assessment tool for dactylitis Philip Helliwell.
Non-Radiographic Spondyloarthritis Has Greater Work Instability than Other Spondyloarthritis Subtypes in a National Database Sherry Rohekar 1, Robert D.
Rehabilitation Teaching and Research Unit, Wellington School of Medicine and Health Sciences Outcome measures in psoriatic arthritis Preliminary identification.
ANKYLOSING SPONDYLITIS (Marie-Strümpell disease/ Bechterew's disease )
AM Report 11/24/09 Amy Auerbach  Peak onset between 20 and 30 years  Form of spondyloarthritis (cause inflammation around site of ligament insertion.
Group for Research and Assessment in Psoriasis and Psoriatic Artritis PGA/VAS Patient and Physician Perception of disease in Psoriatic Arthritis (3PPsA)
GRAPPA research committee Philip Helliwell. History Steering committee in March 2005 received an application for funds to support a research project No.
NSAIDs and Radiographic Progression in Ankylosing Spondylitis By Abd El-Samad El-Hewala Professor of Rheumatology and Rehabilitation Faculty of Medicine.
OMERACT 8 PsA Module Co-Chairs Dafna Gladman and Philip Mease Steering Committee Alice Gottlieb, Philip Helliwell, Arthur Kavanaugh, Gerry Krueger, Peter.
Psoriatic Arthritis Workshop OMERACT May 14 th, 2004 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heijde, Christian.
Welcome to SpA SIG August 2, 2006 MR 304 :
Assessment of enthesitis in psoriatic arthritis
Radiological scoring in Psoriatic Arthritis Application of the OMERACT filter to four scoring methods.
OMERACT 8 PsA Module Co-Chairs Dafna Gladman and Philip Mease Steering Committee Alice Gottlieb, Oliver FitzGerald, Philip Helliwell, Arthur Kavanaugh,
Axial Spondyloarthritis (SpA): Representative Values of Sensitivity and Specificity for Several Tests with the Resulting LRs *LR+ = sensitivity/(1 – specificity);
Some New Ideas for Reliability Studies Stefan Steiner, Jock MacKay and Richard Cook University of Waterloo Quality and Productivity.
Spondyloarthropathies. Introduction Spondyloarthropathy (Spondloarthritis) – Term for a group of chronic diseases – Affecting the joints of the spine.
Group for Research and Assessment in Psoriasis and Psoriatic Artritis PGA/VAS Patient and Physician Perception of disease in Psoriatic Arthritis (3PPsA)
INTEROBSERVER AND INTRAOBSERVER VARIABILITY IN THE C-EOS. COMPARISON BETWEEN EXPERIENCED SPINE SURGEONS AND TRAINEES. María del Mar Pozo-Balado, PhD José.
OMERACT Workshop Outcome Measures in Psoriatic Arthritis
ST05_Mar12 Normative values for the Bath Ankylosing Spondylitis Metrology Index (BASMI) Lucy Chilton-Mitchell 1 Anna Hart, 2 Jane Martindale, 1,2 Lynne.
Outcome Measures in PsA Philip Mease MD Seattle, WA.
Radiological scoring in Psoriatic Arthritis
Psoriatic Arthritis Workshop Part 2 OMERACT May 15 th, 2004 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heidje, Christian.
OMERACT 8 PsA Module Proposal Submitted by: Dafna Gladman and Philip Mease.
GRAPPA Committee Reports and Outcome measures Dafna D. Gladman, MD, FRCPC Professor of Medicine, University of Toronto Director, PsA Program, University.
Psoriatic Arthritis Workshop OMERACT 7 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heijde, Christian Antoni, Philip.
TPMI Research Day Proton Rahman. Burden of Musculoskeletal Diseases MSDs is the second leading cause of disability Overall annual socioeconomic burden.
C-1 Etanercept (Enbrel ® ) for the Treatment of Ankylosing Spondylitis Backup Visuals FDA Arthritis Advisory Committee June 24, 2003.
Department Of Rheumatology : Prevalence of LBA in a tertiary care Naval hospital Surg Cdr A Singhal, Brig R Ramasethu, Surg Cmde KI Mathai, Dr P Malviya.
DESCRIPTION AND VALIDATION OF A SIMPLE CLINICAL TEST TO SORT OUT CHRONIC LOW BACK PAIN. A PILOT STUDY Simon Bergeron¹, O. Maria 1, M-J.Morneau², H.A. Ménard.
Late-Onset Ankylosing Spondylitis R4 김 광 열 / prof. 이 연 아 MGR review.
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis R1 신가영 / Modulator Prof. 이연아 N Engl J Med 2015; 373: Philip J.
Approach to Diagnosis of Ankylosing Spondylitis Iraj Salehi-Abari MD
Ankylosing Spondylitis
Monthly improvements in paid work productivity: ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) subpopulations (employed.
Monthly improvements in family, social and leisure activities to week 96 (last observation carried forward imputation). Assessed using the arthritis-specific.
Monthly improvements in paid work productivity: overall axial spondyloarthritis population (employed patients only; last observation carried forward imputation). Assessed.
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.
Summary of TB cases across indications and trial periods
Part 1: Disease Activity Measures
Expert Insights on Psoriatic Arthritis From Washington, DC
Updated 2016 PsA Core Domain Set.
ASAS 20/40 response rates, and mean change from baseline in BASDAI through week 156* of treatment. *For patients who discontinued, the end of treatment.
What on earth is Spondyloarthritis
Univariate predictors of (A) ASDAS ID (<1
OR for baseline predictors of MDA at weeks 12, 24, 48, 96 and 144 by univariate analysis of observed data. OR for baseline predictors of MDA at weeks 12,
Figure 1 Patterns of joint and organ involvement in rheumatic disease
Relationships between the baseline disease activity scores and scintigraphic sum scores for the patients with RA, pSpA and axSpA. Relationships between.
Algorithm based on the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Algorithm based on the ASAS-EULAR recommendations for.
ULTRASOUND NEWS MARCH 2019.
Psoriatic Spondyloarthropathies Dr Sarah Levy
Monthly improvements in home productivity: ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) subpopulations (last observation.
Efficacy as first, second and third bDMARD in patients with axial spondyloarthritis. ASAS, Assessment of Spondylo Arthritis international Society; BASDAI,
(A) Mean (95% CI) change and (B) mean percentage (SE) change in enthesitis scores (Leeds Enthesitis Index, SPARCC Enthesitis Index, and MASES) from baseline.
Cardiovascular disease risk assessment capture rates in the NOCAR project, evaluated across diagnosis groups and participating centre. Cardiovascular disease.
Presentation transcript:

INternational Spondyloarthritis Inter- observer Reliability Exercise – the INSPIRE study. Gladman DD, Inman RD, Cook R, Maksymowych W, van der Heijde D, Lendewé R, Braun J, Davis J, Mease P Brandt J, Burgos-Vargas R, Chandran V, Helliwell P, Kavanaugh A, Khan MA, O’Shea B, Pipitone N, Rahman P, Reveille JD, Stone M, Taylor W, Veale D, Supported by SPARCC, the Arthritis Society (Canada), Abbott Canada, Amgen/Wyeth Canada, Pfizer Canada, Schering Canada, Wyeth Global,

The INSPIRE Study u Several measures have been used in the assessment of ankylosing spondylitis (AS). u It has not yet been determined whether these measurements are reproducible. u It has not been determined whether these measures are applicable in psoriatic arthritis (PsA) with axial involvement. Background

The INSPIRE study To determine whether the axial measures used in primary AS were reproducible for both AS and PsA with axial disease Objective

The INSPIRE Study u Assessors: 20 rheumatologists from 11 countries with expertise in spondyloarthritis (SpA) –10 experts in AS; 10 experts in PsA u Patients: –10 patients with PsA with axial involvement –9 AS patients u Design: A Latin Square design that enabled assessment of patient, assessor and order effect was used. u Measures: occiput to wall, tragus to wall, cervical rotation, chest expansion, lateral spinal bending, modified Schober, and hip mobility. u Analysis: Intra Class Correlations (ICC) adjusted for order of measurements. Methods

The INSPIRE Study Patient Characteristics GroupASPsA Females/Males7 / 29 / 1 Mean Age (yrs)3852 Disease Duration (yrs)1716

The INSPIRE Study MeasurementASPsA with axial disease Occiput to wall Tragus to wall Cervical rotation Chest expansion Xiphisternum 4 th intercostal Modified Schober Lateral spinal bending BASMI Domjan Modified Domjan Intermalleolar distance Internal Hip rotation 0.81 (0.64,0.94) 0.80 (0.63,0.94) 0.66 (0.43,0.88) 0.57 (0.33,0.84) 0.24 (0.07,0.59) 0.85 (0.70,0.95) 0.83 (0.67,0.95) 0.91 (0.82,0.98) 0.92 (0.83,0.98) 0.78 (0.60,0.93) 0.92 (0.82,0.98) 0.82 (0.66,0.94) 0.67 (0.46,0.88) 0.94 (0.87,0.98) 0.64 (0.42,0.87) 0.70 (0.50,0.89) 0.65 (0.43,0.87) 0.82 (0.66,0.94) 0.85 (0.71,0.95) 0.77 (0.58,0.92) 0.96 (0.91,0.99) 0.92 (0.83,0.97) Spinal Measurements ICC

The INSPIRE Study % total variance due to MeasurePatientAssessorOrder Occiput to wall Tragus to wall 81.8 (<0.001) 79.8 (<0.001) 8.0 (0.003) 3.7 (0.66) 0.1 (0.98) 1.9 (0.13) Cervical rotation68.1 (<0.001)14.3 (0.003)0.1 (0.98) Chest expansion Xiph* Chest expansion 4IC* 58.5 (<0.001) 29.3 (<0.001) 26.2 (<0.001) 40.1 (<0.001) 2.5 (0.06) 1.5 (0.56) Modified Schober84.9 (<0.001)5.3 (0.04)0.7 (0.38) LLB* – BASMI LLB – DOMJAN LLB – INSPIRE 83.3 (<0.001) 91.4 (<0.001) 91.5 (<0.001) 3.9 (0.43) 2.3 (0.24) 1.6 (0.56) 0.4 (0.73) 0.5 (0.30) 1.0 (0.07) Intermalleolar Internal Hip rotation 78.4 (<0.001) 91.5 (<0.001) 5.9 (0.19) 2.0 (0.34) 1.2 (0.31) 0.6 (0.24) Variation in Patients with AS *LLB=lateral lumbar bending; Xiph=xiphisternum; 4IC=4 th intercostal space

The INSPIRE Study % total variance due to MeasurePatientAssessorOrder Occiput to wall Tragus to wall 83.0 (<0.001) 68.0 (<0.001) 7.7 (0.001) 10.0 (0.04) 0.1 (0.97) 1.7 (0.24) Cervical rotation94.0 (<0.001)2.8 (0.001)0.3 (0.20) Chest expansion Xiph* Chest expansion 4IC* 66.2 (<0.001) 72.1 (<0.001) 17.3 (<0.001) 15.7 (<0.001) 2.2 (0.10) 0.2 (0.87) Modified Schober67.1 (<0.001)18.3 (<0.001)1.0 (0.36) LLB* – BASMI LLB – DOMJAN LLB – INSPIRE 82.0 (<0.001) 84.4 (<0.001) 75.8 (<0.001) 2.6 (0.82) 5.1 (0.01) 4.5 (0.46) 1.1 (0.27) 1.4 (0.04) 2.7 (0.04) Intermalleolar Internal Hip rotation 95.3 (<0.001) 91.3 (<0.001) 1.2 (0.04) 2.2 (0.15) 0.9 (<0.001) 0.8 (0.08) Variation in Patients with PsA *LLB=lateral lumbar bending; Xiph=xiphisternum; 4IC=4 th intercostal space

The INSPIRE Study u Substantial to Excellent reliability was noted for: –Occiput-to-wall, cervical rotation, lateral bending, hip mobility, modified Schober’s for both AS and PsA –Chest expansion at xiphisternum for PsA u The majority of the variation was due to patients u Assessor effect was noted for: –Occiput-to-wall, cervical rotation and chest expansion for both AS and PsA, and modified Schober’s for PsA u Order effect was noted only for intermalleolar distance in PsA. Summary

The INSPIRE Study u Measures of spinal mobility are reliable for AS. u Measures of spinal mobility that have been applied to primary AS perform well with respect to inter-observer reliability when applied to PsA patients with axial involvement. u These measures now need to be used in clinical trials and longitudinal cohort studies in PsA to confirm sensitivity to change. Conclusions